Acromégalie et grossesse : six nouvelles observations

Persechini, Marie-Laure; Gennero, Isabelle; Grunenwald, Solange; Vezzosi, Delphine; Bennet, A.; Caron, P.

doi:10.1016/j.jgyn.2013.04.008

Cited by 11 publications

(2 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Breastfeeding is generally possible and not contraindicated (106,110,111,112,113,116,139). As a safety principle, somatostatin analogues and pegvisomant should be avoided in nursing mothers (see section 5.3).…”

Section: Rationalementioning

confidence: 99%

See 1 more Smart Citation

ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy

Luger

Broersen

Biermasz

et al. 2021

European Journal of Endocrinology

View full text Add to dashboard Cite

Pregnancies are rare in women with pituitary adenomas, which may relate to hormone excess from secretory subtypes such as prolactinomas or corticotroph adenomas. Decreased fertility may also result from pituitary hormone deficiencies due to compression of the gland by large tumours and/or surgical or radiation treatment of the lesion. Counselling premenopausal women with pituitary adenomas about their chance of conceiving spontaneously or with assisted reproductive technology, and the optimal pre-conception treatment, should start at the time of initial diagnosis. The normal physiological changes during pregnancy need to be considered when interpreting endocrine tests in women with pituitary adenomas. Dose adjustments in hormone substitution therapies may be needed across the trimesters. When medical therapy is used for pituitary hormone excess, consideration should be given to the known efficacy and safety data specific to pregnant women for each therapeutic option. In healthy women, pituitary gland size increases during pregnancy. Since some pituitary adenomas also enlarge during pregnancy, there is a risk of visual impairment, especially in women with macroadenomas or tumours near the optic chiasm. Pituitary apoplexy represents a rare acute complication of adenomas requiring surveillance, with surgical intervention needed in some cases. This guideline describes the choice and timing of diagnostic tests and treatments from the pre-conception stage until after delivery, taking into account adenoma size, location and endocrine activity. In most cases, pregnant women with pituitary adenomas should be managed by a multidisciplinary team in a centre specialised in the treatment of such tumours.

show abstract

Section: Rationalementioning

confidence: 99%

“…Shortly after delivery, a rebound of disease activity is frequently observed (110,116,124,126,139,267); therefore, early resumption of treatment may be indicated. A postpartum MRI should be performed in most patients with a previously documented adenoma, timing depending on disease severity, and known remnant.…”

Section: Rationalementioning

confidence: 99%